SEARCH

SEARCH BY CITATION

References

  • Adams J. M. and Cory S. (1998) The Bcl-2 protein family: arbiters of cell survival. Science 281, 13221326.
  • Arnoult D., Parone P., Martinou J.-C., Antonsson B., Estaquier J. and Ameisen J. C. (2002) Mitochondrial release of apoptosis-inducing factor occurs downstream of cytochrome c release in response to several proapoptotic stimuli. Sci. Signaling 159, 923.
  • Arriagada P. V., Growdon J. H., Hedley-Whyte E. T. and Hyman B. T. (1992) Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 42, 631639.
  • Azam S., Drobetsky E. and Ramotar D. (2007) Overexpression of the cis/trans isomerase PTPA triggers caspase 3-dependent apoptosis. Apoptosis 12, 12431255.
  • Barinaga M. (1998) Is apoptosis key in Alzheimer's disease? Science 281, 13031304.
  • Biernat J., Wu Y. Z., Timm T., Zheng-Fischhöfer Q., Mandelkow E., Meijer L. and Mandelkow E.-M. (2002) Protein kinase MARK/PAR-1 is required for neurite outgrowth and establishment of neuronal polarity. Mol. Biol. Cell 13, 40134028.
  • Bøe R., Gjertsen B. T., Vintermyr O. K., Houge G., Lanotte M. and Døskeland S. O. (1991) The protein phosphatase inhibitor okadaic acid induces morphological changes typical of apoptosis in mammalian cells. Exp. Cell Res. 195, 237246.
  • Breckenridge D. G. and Xue D. (2004) Regulation of mitochondrial membrane permeabilization by BCL-2 family proteins and caspases. Curr. Opin. Cell Biol. 16, 647652.
  • Cayla X., Goris J., Hermann J., Hendrix P., Ozon R. and Merlevede W. (1990) Isolation and characterization of a tyrosyl phosphatase activator from rabbit skeletal muscle and Xenopus laevis oocytes. Biochemistry 29, 658667.
  • Cohen P. (1989) The structure and regulation of protein phosphatases. Annu. Rev. Biochem. 58, 453508.
  • Cohen G. (1997) Caspases: the executioners of apoptosis. Biochem. J326, 116.
  • Douville J., David J., Lemieux K. M., Gaudreau L. and Ramotar D. (2006) The Saccharomyces cerevisiae phosphatase activator RRD1 is required to modulate gene expression in response to rapamycin exposure. Genetics 172, 13691372.
  • Duan D. X., Chai G. S., Ni Z. F., Hu Y., Luo Y., Cheng X. S., Chen N. N., Wang J. Z. and Liu G. P. (2013) Phosphorylation of tau by death-associated protein kinase 1 antagonizes the kinase-induced cell apoptosis. J. Alzheimer's Dis. 37, 795808.
  • Fellner T., Lackner D. H., Hombauer H., Piribauer P., Mudrak I., Zaragoza K., Juno C. and Ogris E. (2003) A novel and essential mechanism determining specificity and activity of protein phosphatase 2A (PP2A) in vivo. Genes Dev. 17, 21382150.
  • Gottlieb E., Armour S., Harris M. and Thompson C. (2003) Mitochondrial membrane potential regulates matrix configuration and cytochrome c release during apoptosis. Cell Death Differ. 10, 709717.
  • Gupta K., Kshirsagar S., Li W., Gui L., Ramakrishnan S., Gupta P., Law P. Y. and Hebbel R. P. (1999) VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signaling. Exp. Cell Res. 247, 495504.
  • Henshall D. C., Araki T., Schindler C. K., Lan J.-Q., Tiekoter K. L., Taki W. and Simon R. P. (2002) Activation of Bcl-2-associated death protein and counter-response of Akt within cell populations during seizure-induced neuronal death. J. Neurosci. 22, 84588465.
  • Janzen C., Sen S., Cuevas J., Reddy S. T. and Chaudhuri G. (2011) PP2A promotes endothelial survival via stabilization of translational inhibitor 4E-BP1 following exposure to TNFα. Arterioscler. Thromb. Vasc. Biol. 31, 2586.
  • Jordens J., Janssens V., Longin S. et al. (2006) The protein phosphatase 2A phosphatase activator is a novel peptidyl-prolyl cis/trans-isomerase. J. Biol. Chem. 281, 63496357.
  • Jouvet N., Poschmann J., Douville J., Bulet L. and Ramotar D. (2010) Rrd1 isomerizes RNA polymerase II in response to rapamycin. BMC Mol. Biol. 11, 92.
  • Khlistunova I., Biernat J., Wang Y., Pickhardt M., von Bergen M., Gazova Z., Mandelkow E. and Mandelkow E.-M. (2006) Inducible expression of Tau repeat domain in cell models of tauopathy Aggregation is toxic to cells but can be reversed by inhibitor drugs. J. Biol. Chem. 281, 12051214.
  • Kroemer G. (1997) The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat. Med. 3, 614620.
  • Li H., Zhu H., Xu C. J. and Yuan J. (1998) Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94, 491501.
  • Li H. L., Wang H. H., Liu S. J. et al. (2007) Phosphorylation of tau antagonizes apoptosis by stabilizing β-catenin, a mechanism involved in Alzheimer's neurodegeneration. Proc. Natl Acad. Sci. 104, 35913596.
  • Liu X., Kim C. N., Yang J., Jemmerson R. and Wang X. (1996) Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86, 147157.
  • Liu X. A., Song J., Jiang Q., Wang Q., Tian Q. and Wang J.-Z. (2012) Expression of the hyperphosphorylated tau attenuates ER stress-induced apoptosis with upregulation of unfolded protein response. Apoptosis 17, 10391049.
  • Longin S., Jordens J., Martens E. et al. (2004) An inactive protein phosphatase 2A population is associated with methylesterase and can be re-activated by the phosphotyrosyl phosphatase activator. Biochem. J. 380, 111119.
  • Luo Y., Nie Y. J., Shi H. R., Ni Z. F., Wang Q., Wang J.-Z. and Liu G.-P. (2013) PTPA activates protein phosphatase-2A through reducing its phosphorylation at tyrosine-307 with upregulation of protein tyrosine phosphatase 1B. Biochim. Biophys. Acta. 1833, 12351243.
  • Mohamad N., Gutiérrez A., Núñez M., Cocca C., Martín G., Cricco G., Medina V., Rivera E. and Bergoc R. (2005) Mitochondrial apoptotic pathways. Biocell 29, 149161.
  • Muchmore S. W., Sattler M., Liang H. et al. (1996) X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature 381, 335341.
  • Mumby M. C. and Walter G. (1993) Protein serine/threonine phosphatases: structure, regulation, and functions in cell growth. Physiol. Rev. 73, 673699.
  • Parone P. A., James D. I., Da Cruz S., Mattenberger Y., Donzé O., Barja F. and Martinou J.-C. (2006) Inhibiting the mitochondrial fission machinery does not prevent Bax/Bak-dependent apoptosis. Mol. Cell. Biol. 26, 73977408.
  • Porter A. G. and Jänicke R. U. (1999) Emerging roles of caspase-3 in apoptosis. Cell Death Differ. 6, 99.
  • Poschmann J., Drouin S., Jacques P. E., El Fadili K., Newmarch M., Robert F. and Ramotar D. (2011) The peptidyl prolyl isomerase Rrd1 regulates the elongation of RNA polymerase II during transcriptional stresses. PLoS ONE 6, e23159.
  • Sleegers K. and Van Duijn C. (2002) Alzheimer's disease: genes, pathogenesis and risk prediction. Public Health Genomics 4, 197203.
  • Smaili S., Hsu Y., Sanders K., Russell J. and Youle R. (2001) Bax translocation to mitochondria subsequent to a rapid loss of mitochondrial membrane potential. Cell Death Differ., 8, 909920.
  • Valdiglesias V., Laffon B., Pásaro E. and Méndez J. (2011) Okadaic acid induces morphological changes, apoptosis and cell cycle alterations in different human cell types. J. Environ. Monit. 13, 18311840.
  • Van Hoof C., Aly M. S., Garcia A., Cayla X., Cassiman J. J., Merlevede W. and Goris J. (1995) Structure and chromosomal localization of the human gene of the phosphotyrosyl phosphatase activator (PTPA) of protein phosphatase 2A. Genomics 28, 261272.
  • Van Hoof C., Janssens V., De Baere I., de Winde J. H., Winderickx J., Dumortier F., Thevelein J. M., Merlevede W. and Goris J. (2000) The Saccharomyces cerevisiae homologue YPA1 of the mammalian phosphotyrosyl phosphatase activator of protein phosphatase 2A controls progression through the G1 phase of the yeast cell cycle. J. Mol. Biol. 302, 103120.
  • Van Hoof C., Janssens V., De Baere I., Stark M. J., de Winde J. H., Winderickx J., Thevelein J. M., Merlevede W. and Goris J. (2001) The Saccharomyces cerevisiae phosphotyrosyl phosphatase activator proteins are required for a subset of the functions disrupted by protein phosphatase 2A mutations. Exp. Cell Res. 264, 372387.
  • Vaux D. L. and Strasser A. (1996) The molecular biology of apoptosis. Proc. Natl Acad. Sci. 93, 22392244.
  • Wei M. C., Zong W. X., Cheng E. H. Y. et al. (2001) Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292, 727730.
  • Wera S. and Hemmings B. A. (1995) Serine/threonine protein phosphatases. Biochem. J. 311(Pt 1), 1729.
  • Yang G. H., Jarvis B. B., Chung Y. J. and Pestka J. J. (2000) Apoptosis induction by the satratoxins and other trichothecene mycotoxins: relationship to ERK, p38 MAPK, and SAPK/JNK activation. Toxicol. Appl. Pharmacol. 164, 149160.
  • Zhao J., Liu T., Jin S.-B., Tomilin N., Castro J., Shupliakov O., Lendahl U. and Nistér M. (2009) The novel conserved mitochondrial inner-membrane protein MTGM regulates mitochondrial morphology and cell proliferation. J. Cell Sci. 122, 22522262.